Skip to main content
. Author manuscript; available in PMC: 2014 Sep 15.
Published in final edited form as: Clin Cancer Res. 2013 Sep 10;19(18):4941–4950. doi: 10.1158/1078-0432.CCR-13-1253

Figure 2.

Figure 2

Selection of potential target genes based on PIR positivity in tumor samples. 67 of the 72 potential candidate genes were PIR+ (defined as Nanostring count >100) in some the tumor samples (n=59). 33 genes were PIR+ in over 20% of the tumor samples.